Thema: KR7302440003
SK Bioscience, KR7302440003
money-88409_1920.jpg - Foto: THN
SK bioscience stock: Q3 revenue rises 21%, loss narrows
SK bioscience stock is in focus after stronger quarterly sales and a narrower operating loss. IDT and vaccine demand supported the recovery.
ad-hoc-news.de, heute 02:27 Uhr
SK Bioscience, KR7302440003
SK Bioscience targets PCV21 launch in 2029: 2027 results ...
PCV21 results are due in 2027. SK Bioscience stock last closed at KRW 36,300.00 on October 16, 2026, with launch targeted for 2029.
ad-hoc-news.de, 19.10.26 00:26 Uhr
SK Bioscience, KR7302440003
SK Bioscience targets 2029 PCV21 launch: KRW 52,000 target ...
